908 Devices (MASS) Panoramica del titolo
908 Devices Inc. fornisce dispositivi portatili per la spettrometria di massa e l'infrarosso a trasformata di Fourier (FTIR) da utilizzare in applicazioni vitali per la salute e la sicurezza. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 1/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 0/6 |
MASS Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di 908 Devices Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$9.69 |
| Massimo di 52 settimane | US$11.25 |
| Minimo di 52 settimane | US$5.03 |
| Beta | 0.68 |
| Variazione di 1 mese | 10.11% |
| Variazione a 3 mesi | 17.88% |
| Variazione di 1 anno | 70.00% |
| Variazione a 3 anni | 51.17% |
| Variazione a 5 anni | -73.63% |
| Variazione dall'IPO | -80.22% |
Notizie e aggiornamenti recenti
MASS: Higher 2026 Revenue Outlook Will Support A Stronger Share Price
Analysts have raised the 908 Devices fair value estimate from $11 to $13, citing updated assumptions on the discount rate, revenue growth, profit margin, and future P/E that shift their overall price target framework. What’s in the News for 908 Devices 908 Devices updated full year 2026 earnings guidance, setting a revenue range of $68.0 million to $70.0 million and lifting the lower end from $67.0 million.
MASS: Raised 2026 Outlook And Index Removals Will Shape Future P/E
Analysts have raised their fair value estimate for 908 Devices from $10 to $12, citing updates to key assumptions, including the discount rate, revenue growth outlook, profit margin profile, and future P/E expectations. What’s in the News for 908 Devices 908 Devices updated its full year 2026 revenue guidance to a range of $68.0 million to $70.0 million, compared with the previous range of $67.0 million to $70.0 million.908 Devices: Mission Critical Devices Drive Growth
Summary 908 Devices is rated BUY after a 2Q26 earnings beat, strong revenue growth, and a 97% YTD share price gain. MASS benefits from robust demand for chemical detection devices, driven by law enforcement, defense, and volatile geopolitical conditions. Recurring revenue from NIRLab and product upgrades like VipIR underpin stable growth; management raised FY26 revenue guidance to $68–$70M. Valuation remains reasonable at 5.5x forward P/S, supported by a $101.5M cash position, no debt, and narrowing EBITDA losses. Read the full article on Seeking Alpha
MASS: Index Removals Will Set Up A Future Repricing Opportunity
Analysts have updated their fair value estimate for 908 Devices from $12.00 to $14.00, reflecting revised assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for 908 Devices 908 Devices was dropped from the Russell 2500 Growth Benchmark, according to index classification data.Recent updates
MASS: Higher 2026 Revenue Outlook Will Support A Stronger Share Price
Analysts have raised the 908 Devices fair value estimate from $11 to $13, citing updated assumptions on the discount rate, revenue growth, profit margin, and future P/E that shift their overall price target framework. What’s in the News for 908 Devices 908 Devices updated full year 2026 earnings guidance, setting a revenue range of $68.0 million to $70.0 million and lifting the lower end from $67.0 million.MASS: Raised 2026 Outlook And Index Removals Will Shape Future P/E
Analysts have raised their fair value estimate for 908 Devices from $10 to $12, citing updates to key assumptions, including the discount rate, revenue growth outlook, profit margin profile, and future P/E expectations. What’s in the News for 908 Devices 908 Devices updated its full year 2026 revenue guidance to a range of $68.0 million to $70.0 million, compared with the previous range of $67.0 million to $70.0 million.908 Devices: Mission Critical Devices Drive Growth
Summary 908 Devices is rated BUY after a 2Q26 earnings beat, strong revenue growth, and a 97% YTD share price gain. MASS benefits from robust demand for chemical detection devices, driven by law enforcement, defense, and volatile geopolitical conditions. Recurring revenue from NIRLab and product upgrades like VipIR underpin stable growth; management raised FY26 revenue guidance to $68–$70M. Valuation remains reasonable at 5.5x forward P/S, supported by a $101.5M cash position, no debt, and narrowing EBITDA losses. Read the full article on Seeking AlphaMASS: Index Removals Will Set Up A Future Repricing Opportunity
Analysts have updated their fair value estimate for 908 Devices from $12.00 to $14.00, reflecting revised assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for 908 Devices 908 Devices was dropped from the Russell 2500 Growth Benchmark, according to index classification data.MASS: Raised 2026 Revenue Outlook Will Support A Higher Stock Price
Analysts have lifted their price target on 908 Devices stock from $10.00 to $11.00, citing updated assumptions around fair value, revenue growth, discount rate and future P/E that they consider better aligned with the company's current outlook. What’s in the News for 908 Devices 908 Devices raised its full year 2026 revenue guidance, according to a key developments summary.MASS: Raised 2026 Revenue Outlook Will Support Higher Future P/E Multiple
Analysts have modestly adjusted their price targets on 908 Devices, reflecting updated assumptions for a fair value of $10.00, a slightly higher discount rate, marginally stronger projected revenue growth, a softer profit margin outlook, and a higher future P/E of about 70x. What's in the News 908 Devices raised its full year 2026 revenue guidance to a range of $67.0 million to $70.0 million.MASS: Raised 2026 Revenue Guidance Will Support Higher Earnings Multiple
Analysts have reset their price target on 908 Devices to $10.00 from $8.00, citing updated assumptions around revenue growth, profitability, and future P/E that feed into a higher fair value estimate and a modestly higher discount rate. What's in the News 908 Devices raised full year 2026 revenue guidance to a range of $67.0 million to $70.0 million, compared with 2025 revenue, with the range described as representing 19% to 25% growth (Corporate Guidance: Raised).908 Devices Inc.'s (NASDAQ:MASS) 29% Price Boost Is Out Of Tune With Revenues
Those holding 908 Devices Inc. ( NASDAQ:MASS ) shares would be relieved that the share price has rebounded 29% in the...Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. ( NASDAQ:MASS ) shareholders won't be pleased to see that the share price has had a very rough month...908 Devices Inc.'s (NASDAQ:MASS) Share Price Not Quite Adding Up
When close to half the companies in the Electronic industry in the United States have price-to-sales ratios (or "P/S...908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results
NasdaqGM:MASS 1 Year Share Price vs Fair Value Explore 908 Devices's Fair Values from the Community and select yours...US Federal And International Funding Will Expand Global Analysis Markets
The notable increase in 908 Devices’ price target reflects improved outlook due to higher expected revenue growth and an expanded forward P/E, raising the consensus fair value from $6.50 to $9.00. What's in the News 908 Devices raised its 2025 revenue guidance to $54–56 million (13–17% growth), up from prior guidance of $53–55 million.908 Devices Inc.'s (NASDAQ:MASS) Shares Climb 26% But Its Business Is Yet to Catch Up
Despite an already strong run, 908 Devices Inc. ( NASDAQ:MASS ) shares have been powering on, with a gain of 26% in the...
The New Handheld Mass Spectrometer Launch Will Expand Market Reach
Divesting the desktop bioprocessing portfolio boosts cash reserves, streamlines operations, and is expected to enhance margins and cash flow in future years.908 Devices Makes Key Divestiture (Rating Upgrade)
Summary 908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year. Read the full article on Seeking Alpha908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors
The 908 Devices Inc. ( NASDAQ:MASS ) share price has done very well over the last month, posting an excellent gain of...Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
The analysts might have been a bit too bullish on 908 Devices Inc. ( NASDAQ:MASS ), given that the company fell short...908 Devices: Key Investor Now Selling
Summary ARK Invest's recent sales of 908 Devices shares have helped to send the stock to multi-year lows. 908 Devices is seeing decent revenue growth, but large losses and limited financial flexibility raise concerns about future capital needs. The stock's low valuation compared to peers is a positive, but ongoing sales by ARK Invest could exert further downward pressure. Read the full article on Seeking AlphaWhy We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
To the annoyance of some shareholders, 908 Devices Inc. ( NASDAQ:MASS ) shares are down a considerable 29% in the last...We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
When you see that almost half of the companies in the Electronic industry in the United States have price-to-sales...Rendimenti per gli azionisti
| MASS | US Electronic | US Mercato | |
|---|---|---|---|
| 7D | -6.2% | 4.9% | -0.2% |
| 1Y | 70.0% | 47.7% | 14.8% |
Ritorno vs Industria: MASS ha superato il US Electronic che ha restituito 47.7 % nell'ultimo anno.
Rendimento vs Mercato: MASS ha superato il mercato US che ha restituito 14.8 % nell'ultimo anno.
Volatilità dei prezzi
| MASS volatility | |
|---|---|
| MASS Average Weekly Movement | 7.6% |
| Electronic Industry Average Movement | 9.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Prezzo delle azioni stabile: MASS non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 8% ) di MASS è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2012 | 172 | Kevin Knopp | 908devices.com |
908 Devices Inc. fornisce dispositivi palmari per la spettrometria di massa e l'infrarosso a trasformata di Fourier (FTIR) da utilizzare in applicazioni vitali per la salute e la sicurezza. I prodotti dell'azienda includono MX908, un dispositivo portatile alimentato a batteria e con spettro di massa, progettato per l'analisi rapida di materiali solidi, liquidi, vapori e aerosol di identità sconosciuta; XplorIR, un dispositivo portatile che utilizza la spettroscopia FTIR per identificare, quantificare e tracciare gas e vapori; ThreatID, un dispositivo FTIR portatile che rileva e identifica rapidamente circa 28.000 rischi chimici sconosciuti in gas, vapori, polveri e liquidi; ProtectIR, un dispositivo FTIR portatile in grado di identificare circa 23.000 rischi chimici solidi e liquidi; e VipIR, un analizzatore portatile 3 in 1 che integra FTIR, spettroscopia Raman ed elaborazione spettrale intelligente (SSP), un algoritmo proprietario, per fornire un unico risultato da un solo campione. L'azienda opera negli Stati Uniti, in Europa, Medio Oriente, Africa, Asia e Pacifico e nel resto delle Americhe.
908 Devices Inc. Riepilogo dei fondamenti
| MASS statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$405.48m |
| Utili (TTM) | -US$34.38m |
| Ricavi(TTM) | US$60.84m |
MASS è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| MASS Conto economico (TTM) | |
|---|---|
| Ricavi | US$60.84m |
| Costo del fatturato | US$28.81m |
| Profitto lordo | US$32.03m |
| Altre spese | US$66.41m |
| Utili | -US$34.38m |
Ultimi utili riportati
Jun 30, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | -0.83 |
| Margine lordo | 52.65% |
| Margine di profitto netto | -56.51% |
| Rapporto debito/patrimonio netto | 0% |
Come si è comportato MASS nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/09 18:18 |
| Prezzo dell'azione a fine giornata | 2026/09/09 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
908 Devices Inc. è coperta da 5 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Max Masucci | Roth Capital Partners |
| Daniel Arias | Stifel, Equities Research |